期刊文献+

西布曲明对映体的毛细管电泳分离及结合常数的测定 被引量:1

Chiral separation and binding constants measurement of Sibutramine enantiomers by capillary electrophoresis
原文传递
导出
摘要 目的采用毛细管电泳法分离西布曲明对映体并测定其结合常数。方法考察手性添加剂浓度、缓冲溶液pH及浓度、温度、分离电压等因素对分离度的影响,并采用双倒数法计算西布曲明对映体与2,6-二甲基-β-环糊精(DM-β-CD)的结合常数。结果在12.5mmol·L-1DM-β-CD、100mmol·L-1Tris-H3PO4(pH2.5)缓冲液、16℃柱温,30kV操作电压的毛细管电泳条件下,西布曲明对映体在9min内获得了良好分离,分离度达2.0;结合常数分别为154.4、173.3L·mol-1。结论所用高效毛细管电泳方法快速、准确、可靠,适用于西布曲明对映体的分离;结合常数的计算可为研究西布曲明对映体的拆分机理提供依据。 OBJECTIVE A method for separation of sibutramine enantiomers by capillary electrophoresis was set up. And the binding constants was measured. METHODS The effect of the concentration of chiral selector, pH and concentration of buffer, capillary temperature and separation voltage were investigated respectively. The binding constants of sibutramine enantiomers and DM-β-CD were calculated by the double - reciprocal method. RESULTS The optimized HPCE conditions of sibutramine enantiomers were 12.5 mmol·L^-1 of DM -J3 -CD, 100 mmol·L^-1 of buffer (pH2.5)with capillary temperature of 16 ℃ and separation voltage of 30 kV. Sibutramine enautiomers were completely separated within 9.0 min. The resolution was 2.0. The binding constants were 154.4 L·mol^-1 and 173.3 L·mol^-1. CONCLUSION The established HPCE method is rapid and accurate and reliable,which is suitable for separation of sibutramine enantiomers. The binding constants calculated provide the basis for researching the separation mechanism of sibutramine enantiomers.
出处 《华西药学杂志》 CAS CSCD 北大核心 2010年第1期98-100,共3页 West China Journal of Pharmaceutical Sciences
基金 广州市科技计划项目(2006Z2-E4011) 广东省教育厅自然科学研究重点项目(04Z008)
关键词 高效毛细管电泳 西布曲明 对映体拆分 2 6-二甲基-β-环糊精 结合常数 HPCE Sibutramine Enantiomerie separation DM-β-CD Binding constants
  • 相关文献

参考文献5

二级参考文献31

  • 1蔡梅,李忠红,杨丹.硫酸沙丁胺醇的手性分离[J].药物分析杂志,2006,26(2):159-161. 被引量:5
  • 2George A, Bray GA.Medicinal strategies in thes treatment of obesity [ J] .Nature, 2000, 404(6): 672~677
  • 3靳晓红.减肥药千万别乱吃.环球时报,2002,07:22
  • 4Luque CA, Rey JA.The discovery and status of Sibutramine as an anti-obesity drug [ J] .Eur J Pharmacol, 2002,440 (2~3): 119.128
  • 5Mcneely W, Goa KL.Sibutramine: areview of its contribution to the management of obesity [J] .Drugs, 1998, 56(6): 1093~1124
  • 6Yang JW. ( Sepracor Inc. ) Methods and composition for treating depression and other disorders using optically pure ( + ) sibutramine.PCT Int. Appl. WO 9400047 ( Cl. A51K31/45) ,06 Jan 1994,US Appl. 903034,23 Jun 1992 ;40pp.
  • 7Yang JW. ( Sepracor Inc. ) Pharnlaceutical compositions for treating depression and other cerebral disorders containing optically pure( - )sibutramine. PCT Int. Appl. WO 9400114( Cl. A61 K31/135 ) ,06 Jan1994, US Appl. 903040,23 Jun 1992 ;40pp.
  • 8Radhakrishna T, Narayana CL, Rao DS,et al. LC method for the determination of assay and purity of sibutramine hydrochlorlde and its enantiomers by chiral chromatography. J Pharm Biomed Anal ,2000,22 :627.
  • 9Lelievnre F, Gareil P. Selectivity in capillary electrophoresis : application to chiral separations with cyclodextrins. Anal Chem, 1997,69:385.
  • 10Wren SAC, Rowe RC. Theoretieal aspects of chiral separation in capillary electrophoresis Ⅱ. The role of organic solvent. J Chromatogr,1992,609:363.

共引文献28

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部